KCM
LLY icon

KRS Capital Management’s Eli Lilly LLY Stock Holding History

KRS Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.04M Buy
5,216
+6
+0.1% +$7.08K 2.68% 6
2026
Q2 		$6.25M Buy
5,210
+7
+0.1% +$7.15K 2.91% 6
2026
Q1 		$4.79M Sell
5,203
-4
-0.1% -$4.06K 2.93% 5
2025
Q4 		$5.6M Sell
5,207
-27
-0.5% -$25.8K 3.22% 5
2025
Q3 		$3.99M Buy
5,234
+206
+4% +$153K 2.41% 6
2025
Q2 		$3.92M Hold
5,028
– – 2.62% 7
2025
Q1 		$4.15M Buy
5,028
+122
+2% +$102K 3.3% 4
2024
Q4 		$3.79M Buy
4,906
+156
+3% +$129K 2.68% 5
2024
Q3 		$4.21M Sell
4,750
-20
-0.4% -$18K 3.07% 4
2024
Q2 		$4.32M Buy
4,770
+16
+0.3% +$12.8K 3.23% 4
2024
Q1 		$3.7M Sell
4,754
-235
-5% -$167K 2.98% 4
2023
Q4 		$2.91M Buy
4,989
+201
+4% +$117K 2.71% 4
2023
Q3 		$2.57M Buy
4,788
+57
+1% +$29.4K 2.74% 5
2023
Q2 		$2.22M Buy
4,731
+22
+0.5% +$9.23K 2.22% 6
2023
Q1 		$1.62M Buy
4,709
+443
+10% +$149K 1.82% 6
2022
Q4 		$1.56M Buy
4,266
+293
+7% +$104K 2.13% 5
2022
Q3 		$1.28M Buy
3,973
+861
+28% +$273K 1.77% 7
2022
Q2 		$1.01M Buy
3,112
+27
+0.9% +$8.1K 1.44% 15
2022
Q1 		$883K Buy
3,085
+2
+0.1% +$515 0.96% 26
2021
Q4 		$851K Buy
+3,083
New +$782K 0.73% 31

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

KRS Capital Management's LLY Position: Q3 2026 in Review

KRS Capital Management increased its Eli Lilly (LLY) stake by 0.12% in Q3 2026, buying an estimated $7.08K and bringing the position to 5,216 shares worth $6.04M. The position accounts for 2.68% of the portfolio, ranked #6.

KRS Capital Management first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $6.25M in Q2 2026. 2,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • KRS Capital Management held 5,216 shares of Eli Lilly worth $6.04M as of Q3 2026.
  • KRS Capital Management bought 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
  • Eli Lilly made up 2.68% of KRS Capital Management's portfolio in Q3 2026, its #6 holding.
  • KRS Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
  • KRS Capital Management's Eli Lilly position peaked at $6.25M in Q2 2026.
  • 2,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on KRS Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.